3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
7
Not yet recruiting
6
Completed
3
Withdrawn
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Primary Myelofibrosis
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
trametinib
2
fludarabine
2
thymoglobulin
1
talimogene laherparepvec
1
fludarabine phosphate
1
dabrafenib
1
abemaciclib
1
Waiting Lists
1
Rituximab
1
Photochemotherapy
1
Melphalan
1
Liquid Biopsy
1
Levetiracetam
1
Injections
1
Cytarabine
1
Cyclophosphamide
1
Busulfan
1
Azacitidine
1
Aminolevulinic Acid
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neurofibromatosis 1
×
AZD 6244
×
Clear all
NCT06188741
2026-05-29
NF114
University of Alabama at Birmingham
Phase 2
Recruiting
200 enrolled